References
- 1. Agampodi TC, Agampodi SB, Wickramasinghe WA, Adhikari AM, Chathurani HK. Post partum depression - a problem that needs urgent attention. Ceylon Med J. 2011; 56(4): 183-184.
- 2. Beck CT, Gable RK. Comparative analysis of the performance of the Postpartum Depression Screening Scale with two other depression instruments. Nurs Res. 2001; 50(4): 242-250.
- 3. Birdsall TC. 5-Hydroxytryptophan: a clinicallyeffective serotonin precursor. Altern Med Rev. 1998; 3(4): 271-280.
- 4. Richerson GB, Buchanan GF. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia. 2011; 52(Suppl 1): 28-38.
- 5. Rahman S, Khan IA, Thomas P. Tryptophan hydroxylase: a target for neuroendocrine disruption. J Tox-icol Environ Health B Crit Rev. 2011; 14(5-7): 473-494.
- 6. Craig SP, Boularand S, Darmon MC, Mallet J, Craig IW. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization. Cytogenet Cell Genet. 1991; 56(3-4): 157-159.
- 7. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003; 66(9): 1673-1680.
- 8. Jonsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, et al. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci. 1997; 247(6): 297-302.
- 9. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res. 1997; 45(1): 145-148.
- 10. Chen GL, Miller GM. Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(2): 152-171.
- 11. Mokrovic G, Matosic A, Hranilovic D, Stefulj J, Novokmet M, Oreskovic D, et al. Alcohol dependence and polymorphisms of serotonin-related genes: association studies. Coll Antropol. 2008; 32(Suppl 1): 127-131.
- 12. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, et al. Loss-offunction mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005; 45(1): 11-16.
- 13. Egawa J, Watanabe Y, Nunokawa A, Endo T, Kaneko N, Tamura R, et al. A detailed association analysis between the tryptophan hydroxylase 2 (TPH2) gene and autism spectrum disorders in a Japanese population. Psychiatry Res. 2012; 196(2-3): 320-322.
- 14. Fudalej S, Ilgen M, Fudalej M, Kostrzewa G, Barry K, Wojnar M, et al. Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide. Suicide Life Threat Behav. 2010; 40(6): 553-560.
- 15. Ramamoorthy S, Cool DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD, et al. Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarci-noma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem. 1993; 268(29): 21626-21631.
- 16. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996; 66(6): 2621-2624.
- 17. Wray NR, James MR, Gordon SD, Dumenil T, Ryan L, Coventry WL, et al. Accurate, Largescale genotyping of 5HTTLPR and flanking single nucleotide poly-morphisms in an association study of depression, anxiety, and personality measures. Biol Psychiatry. 2009; 66(5): 468-476.
- 18. Cervilla JA, Molina E, Rivera M, Torres-Gonzalez F, Bellon JA, Moreno B, et al. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry. 2007; 1(8): 748-755.
- 19. Coventry WL, James MR, Eaves LJ, Gordon SD, Gillespie NA, Ryan L, et al. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am J Med Genet B Neuro-psychiatr Genet. 2010; 153B(3): 757-765.
- 20. Shinozaki G. The integrated model of serotonin transporter gene variation (5HTTLPR) and the glial cell transporter in stress vulnerability and depression. Med Hypotheses. 2012; 78(3): 410-414.
- 21. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10- item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987; 150(6): 782-786.
- 22. Porter RJ, Gallagher P, O’Brien JT. Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly. J Psychopharmacol. 2007; 21(1): 71-75.
- 23. Khabour OF, Mesmar FS, Al-Tamimi F, Al- Batay-neh OB, Owais AI. Missense mutation of the EDA gene in a Jordanian family with X-linked hypohidrotic ectodermal dysplasia: phenotypic appearance and speech problems. Genet Mol Res. 2010; 9(2): 941-948.
- 24. Middeldorp CM, de Geus EJ, Beem AL, Lakenberg N, Hottenga JJ, Slagboom PE, et al. Family based association analyses between the serotonin transporter gene polymorphism (5-HTTLPR) and neuroticism, anxiety and depression. Behav Genet. 2007; 37(2): 294-301.
- 25. Mansour HA, Talkowski ME, Wood J, Pless L, Bamne M, Chowdari KV, et al. Serotonin gene polymor- phisms and bipolar I disorder: focus on the serotonin transporter. Ann Med. 2005; 37(8): 590-602.
- 26. Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, et al. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol Psychiatry. 1999; 4(4): 389-392.
- 27. Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E, Lorenzi C, et al. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet. 2002; 114(4): 361-369.
- 28. Sun HS, Tsai HW, Ko HC, Chang FM, Yeh TL. Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comor bid depression and anxiety in a population-based sample of postpartum Taiwanese women. Genes Brain Behav. 2004; 3(6): 328-336.
- 29. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med. 2005; 35(1): 101-111.
- 30. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry. 2006; 59(3): 224-229.
- 31. Sanjuan J, Martin-Santos R, Garcia-Esteve L, Carot JM, Guillamat R, Gutierrez-Zotes A, et al. Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry. 2008; 193(5): 383-388.
- 32. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005; 10(2): 220-224.
- 33. Chaaya M, Campbell OM, El Kak F, Shaar D, Harb H, Kaddour A. Postpartum depression: prevalence and determinants in Lebanon. Arch Womens Ment Health. 2002; 5(2): 65-72.
- 34. Halbreich U, Karkun S. Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms. J Affect Disord. 2006; 91(2-3): 97-111.
- 35. O’Hara MW, Schlechte JA, Lewis DA, Varner MW. Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol. 1991; 100(1): 63-73.
- 36. Rich-Edwards JW, Kleinman K, Abrams A, Harlow BL, McLaughlin TJ, Joffe H, et al. Sociodemo- graphic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health. 2006; 60(3): 221-227.
- 37. Chung EK, McCollum KF, Elo IT, Lee HJ, Culhane JF. Maternal depressive symptoms and infant health practices among low-income women. Pediatrics. 2004; 113(6): e523-e529.
- 38. Gjerdingen DK, Chaloner KM. The relationship of women’s postpartum mental health to employment, childbirth, and social support. J Fam Pract. 1994; 38(5): 465-472.
- 39. Chaudron LH, Klein MH, Remington P, Palta M, Allen C, Essex MJ. Predictors, prodromes and incidence of postpartum depression. J Psychosom Obstet Gynaecol. 2001; 22(2): 103-112.
- 40. Josefsson A, Angelsioo L, Berg G, Ekstrom CM, Gunnervik C, Nordin C, et al. Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet Gynecol. 2002; 99(2): 223-228.
- 41. Husain N, Bevc I, Husain M, Chaudhry IB, Atif N, Rahman A. Prevalence and social correlates of postnatal depression in a low income country. Arch Womens Ment Health. 2006; 9(4): 197-202.
- 42. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000; 157(10): 1552-1562.